Autoimmune Dysautonomia Evaluation

Autoimmune Dysautonomia

July 2012

When taking the history from a patient with autoimmune dysautonomia, diagnostic clues that may arise in the history, include a personal or family history of autoimmunity or cancer.  One of the key reasons why diagnosing a paraneoplastic autoimmune dysautonomia is important rests in the fact that when a cancer is detected in this setting it is usually a limited stage and is more easily treatable, thereby lessening morbidity from the cancer.  Another reason for early detection of these disorders lies in the fact that many of these patients improve considerably with immunotherapy or oncological therapies for a related cancer when the diagnosis is made early.

< Previous Slide

Autoimmune Dysautonomia

Next Slide >

 

Jump to section:

• Introduction
• New Profile
• Autoimmune Dysautonomia
• Autoimmune Dysautonomia
• Autoimmune Dysautonomia^1,2
• Pandysautonomia
• Limited Dysautonomia³
• Objective Testing
• Thermoregulatory Sweat Testing: Measuring Heat-Induced Sweating
• Antibody Testing in Autoimmune Dysautonomia
• Antibody Testing in Autoimmune Dysautonomia
• Ganglionic Acetylcholine Receptor (AChR) Autoantibody
• Ganglionic AChR Autoantibody
• Autoimmune Dysautonomia Antibody Profile
• ADE/89904 Autoimmune Dysautonomia Evaluation, Serum Algorithm
• ADE/89904 Autoimmune Dysautonomia Evaluation, Serum Algorithm
• ADE/89904 Autoimmune Dysautonomia Evaluation, Serum Algorithm
• ADE/89904 Autoimmune Dysautonomia Evaluation, Serum Algorithm
• Clinical Utility of Autoimmune Dysautonomia Evaluation
• Clinical Utility of Autoimmune Dysautonomia Evaluation
• Summary
• References
• Questions